Elf5 Regulates Mammary Gland Stem/Progenitor Cell Fate by Influencing Notch Signaling
The transcription factor E74‐like factor 5 (Elf5) functions downstream of the prolactin receptor signaling pathway and plays an important role in mammary gland development. Using conditional mouse knockouts, we have previously shown that Elf5‐null mammary glands exhibit a complete failure of alveolo...
Saved in:
Published in | Stem cells (Dayton, Ohio) Vol. 30; no. 7; pp. 1496 - 1508 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.07.2012
Oxford University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The transcription factor E74‐like factor 5 (Elf5) functions downstream of the prolactin receptor signaling pathway and plays an important role in mammary gland development. Using conditional mouse knockouts, we have previously shown that Elf5‐null mammary glands exhibit a complete failure of alveologenesis during pregnancy. The Elf5‐null developmental phenotype is mediated through alteration in the expression of several critical genes involved in alveologenesis, particularly those belonging to the JAK/STAT pathway. Here, we demonstrate that in addition to regulating terminal differentiation of alveolar cells, Elf5 also plays a critical role in determining cell fate and in regulating the stem/progenitor function of the mammary epithelium. Targeted deletion of Elf5 in the mammary glands leads to accumulation of cell types with dual luminal/basal properties such as coexpression of K8 and K14 and an increase in CD61+ luminal progenitor population during pregnancy. Further interrogation suggests that the abnormal increase in K14+K8+ cells may represent the CD61+ luminal progenitors blocked in differentiation. Remarkably, Elf5 deficiency in mammary epithelium also triggers an increase of adult mammary stem activity as evidenced by the accumulation of mammary stem cell (MaSC)‐enriched cell population in both pregnant and virgin mice and further confirmed by mammosphere and transplantation assays. Additional support for this phenotype comes from the enriched MaSC gene signature based on transcriptomic analysis of the Elf5‐null mammary gland. Finally, our biochemical studies suggest that Elf5 loss leads to hyperactivation of the Notch signaling pathway, which might constitute in part, the underlying molecular mechanism for the altered cell lineage decisions in Elf5‐null mammary epithelial cells. STEM CELLS2012;30:1496–1508 |
---|---|
Bibliography: | First published online in STEM CELLSEXPRESS April 20, 2012. istex:B0CC685E2C8C06F3B9FE1CCF3CDC9279ACCA4F8F DOD postdoctoral fellowship - No. W81XWH-11-1-0681 ArticleID:STEM1112 Disclosure of potential conflicts of interest is found at the end of this article. Brewster Foundation, the Champalimaud Foundation - No. R01GM069417 ark:/67375/WNG-WDBXW627-Q National Institutes of Health - No. R01CA134519; No. R01CA141062 Author contributions: R.C.: conception, design, collection of data, analysis, and manuscript writing; Y.W.: technical support and analysis; R.R.: technical support; C.D.: collection of data; Y.K.: manuscript writing; S.S.: conception, analysis, and manuscript writing. Department of Defense First published online in S C XPRESS April 20, 2012. E Fax: 716‐849‐6655 Fax: 609‐258‐2340 TEM ELLS ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1066-5099 1549-4918 |
DOI: | 10.1002/stem.1112 |